Only fungi make it. Ergothioneine is a sulfur antioxidant that plants and animals can't build, so we get it almost entirely from mushrooms 1. What sets it apart from every other antioxidant in your diet is the plumbing: your cells carry a delivery protein, OCTN1, essentially specific to this one molecule 2. Evolution doesn't build dedicated transporters for molecules that don't matter.
It ends up concentrated hundreds of times over in the tissues under the most oxidative stress: red blood cells, the lens of the eye, the brain 3. And it lingers: its blood half-life is about thirty days, ten times longer than vitamin C, so the mushrooms you ate three weeks ago are still on duty 4.
The human signal is observational but strong. In 3,236 Swedish adults tracked for two decades, the top quartile of blood ergothioneine had about 21% lower cardiovascular death and 14% lower all-cause death than the bottom, after the usual adjustments 5. In Singapore, adults over sixty who ate more than two portions of mushrooms a week were roughly half as likely to have mild cognitive impairment 6. Blood levels also fall with age, faster after sixty, and are lower in people already declining 7.
What's missing is a placebo trial, and it may never come: the molecule is off-patent, so nobody will fund fifteen years of study 8.
Two roads: the mushroom aisle or a capsule. Pick mushrooms.
Mushrooms win because they're food, they're cheap, and they're what the people who lived longer were actually eating.
You won't feel a thing, and that's the deal. This is prevention, about events that never happen. Blood levels climb over weeks; red blood cell stores reach steady state in two to four months 4. The payoff is a slower decline curve you can't point to: the heart attack that doesn't come at sixty-eight, the cognitive slide that doesn't start at seventy-eight. Twenty years of mushroom meals put you in the top blood quartile of the Swedish cohort instead of the bottom one 5.
The fine print — when to skip it, and what people get wrong
- 1Cheah IK, Halliwell B (2012). Ergothioneine; antioxidant potential, physiological function and role in disease. Biochimica et Biophysica Acta - Molecular Basis of Disease. link
- 2Gründemann et al. (2005). Discovery of the ergothioneine transporter. Proceedings of the National Academy of Sciences. link
- 3Paul BD, Snyder SH (2010). The unusual amino acid L-ergothioneine is a physiologic cytoprotectant. Cell Death and Differentiation. link
- 4Halliwell B, Cheah IK, Tang RMY (2018). Ergothioneine - a diet-derived antioxidant with therapeutic potential. FEBS Letters. link
- 5Smith et al. (2020). Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease. Heart. link
- 6Feng et al. (2019). The Association between Mushroom Consumption and Mild Cognitive Impairment: A Community-Based Cross-Sectional Study in Singapore. Journal of Alzheimer's Disease. link
- 7Cheah et al. (2016). Ergothioneine levels in an elderly population decrease with age and incidence of cognitive decline; a risk factor for neurodegeneration? Biochemical and Biophysical Research Communications. link
- 8Borodina et al. (2020). The biology of ergothioneine, an antioxidant nutraceutical. Nutrition Research Reviews. link
- 9Kalaras et al. (2017). Mushrooms: A rich source of the antioxidants ergothioneine and glutathione. Food Chemistry. link
- 10EFSA (2017). Safety of synthetic L-ergothioneine as a novel food pursuant to Regulation (EC) No 258/97. link
Ergothioneine
Mushrooms cost ~$3-8/200g pack; three to five portions a week adds maybe $5-10/week to the grocery bill. Synthetic L-ergothioneine supplementation runs $10-25/month.
A few mushroom-heavy meals per week, or one capsule. ~30-day blood half-life means missed days are forgiven; no complex protocol.
Highest-quartile plasma ergothioneine associated with ~21% lower cardiovascular mortality and ~14% lower all-cause mortality in 3,236 Swedish adults over 20.7y (Smith et al. 2020); >2 mushroom portions/week associated with ~50% lower MCI odds in the Singapore Longitudinal Aging Study (Feng et al. 2019). Mechanism (radical scavenging in tissues where it concentrates) and dedicated mammalian transporter (Gründemann et al. 2005) support the observational signal. Not RCT-confirmed.
Two large observational cohorts (Smith et al. 2020; Feng et al. 2019) with replicated signal, biologically coherent mechanism, dedicated mammalian transporter, knockout-mouse data. No RCT against any hard clinical endpoint. Honest grade: promising and replicated, not confirmed.
Mechanistic plausibility (ergothioneine concentrates in skin via OCTN1 and quenches the oxidative damage that drives photoaging) is good, but dietary intake has not been shown to produce a measurable change in skin appearance in humans (Halliwell et al. 2018). A minor side-effect of better general health, not a primary effect.